InvestorsHub Logo
Followers 23
Posts 1725
Boards Moderated 0
Alias Born 09/03/2015

Re: laraz5 post# 15669

Thursday, 01/18/2018 11:08:59 AM

Thursday, January 18, 2018 11:08:59 AM

Post# of 21373
Yeah they can't disclose any information now that Oncolix is a publicly traded company. That would be insider trading. I spoke with Lisa regarding the previous trial that took place back in 2016. Lisa hadn't heard from Oncolix since that trial ended and the company was still privately held. So unless Lisa was closely following the activities of Oncolix it's highly unlikely she would have known about the reverse merger or the company going public.

Basically your email just confirmed for all of us that Oncolix is back in communication with the trial site and had them sign a confidentiality agreement so they do not disclose any more information to shareholders regarding the ongoing trial. So if one were to connect the dots, that right there tells you that these trials are definitely about to happen and not some BS cohort.

The confidentially agreement is put into effect by the sponsor (Oncolix).

Here is some info regarding confidentiality agreements:

"Please note that some sponsors do not require a CDA prior to releasing a protocol."

That's because a CDA is not required for sponsors of a private company. Sponsors need to request a CDA from the principal investigator, especially if it's a public company.

Here's a link about the CDA's:

https://research.uci.edu/sponsored-projects/clinical-trials/cda.html

Thank you so much for your great DD and confirmation! Trials are just about underway!

Go ONCX!!!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.